The identification of missense mutations of TARDBP, the gene encoding TDP-43, in familial and sporadic ALS and/or FTLD patients further confirmed the importance of this molecule in the pathogenesis of TDP-43 proteinopathies [4]–[7]. The gene discussed is TARDBP; the disease is proteostasis deficiencies.